1,316
Views
0
CrossRef citations to date
0
Altmetric
Emerging and Re-Emerging Coronaviruses

Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023

, , , , , , , , , , , , , , , , , , & show all
Article: 2292071 | Received 06 Jul 2023, Accepted 03 Dec 2023, Published online: 06 Feb 2024

References

  • WHO. WHO Coronavirus (COVID-19) dashboard June 28 2023 [cited 2023 July 5]. Available from: https://covid19.who.int/
  • Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28(11):2398–2405. doi: 10.1038/s41591-022-02051-3. PubMed PMID: 36357676; PubMed Central PMCID: PMCQ1. eng.
  • China NHCotPRo. The 10th version of the national COVID-19 protocol 2023 [cited 2023 October 18]. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202301/32de5b2ff9bf4eaa88e75bdf7223a65a.shtml
  • District SNH. Southern Nevada Health District. B.1.617.2 variant detected in Clark County 2023 [cited 2023 July 5]. Available from: https://www.southernnevadahealthdistrict.org/news-release/b-1-617-2-variant-detected-in-clark-county/
  • District SNH. Southern Nevada Health District reports first Omicron case in Clark County resident 2021 [cited 2023 July 5]. Available from: https://www.southernnevadahealthdistrict.org/news-release/southern-nevada-health-district-reports-first-omicron-case-in-clark-county-resident
  • Hall V, Foulkes S, Insalata F, et al. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection. N Engl J Med. 2022;386(13):1207–1220. doi: 10.1056/NEJMoa2118691. PubMed PMID: 35172051; PubMed Central PMCID: PMCQ1. eng.
  • (US) CfDCaP. Science brief: SARS-CoV-2 infection-induced and vaccine-induced immunity 2021 [cited 2023 July 5]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK575088/
  • Altarawneh HN, Chemaitelly H, Hasan MR, et al. Protection against the Omicron variant from previous SARS-CoV-2 infection. N Engl J Med. 2022;386(13):1288–1290. doi: 10.1056/NEJMc2200133. PubMed PMID: 35139269; PubMed Central PMCID: PMCQ1. eng.
  • Nguyen NN, Houhamdi L, Hoang VT, et al. High rate of reinfection with the SARS-CoV-2 Omicron variant. J Infect. 2022;85(2):174–211. doi:10.1016/j.jinf.2022.04.034. PubMed PMID: 35472367; PubMed Central PMCID: PMCQ1. eng.
  • Mensah AA, Lacy J, Stowe J, et al. Disease severity during SARS-COV-2 reinfection: a nationwide study. J Infect. 2022;84(4):542–550. doi: 10.1016/j.jinf.2022.01.012. PubMed PMID: 35085659; PubMed Central PMCID: PMCQ1. eng.
  • Sotoodeh Ghorbani S, Taherpour N, Bayat S, et al. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: a systematic review and meta-analysis. J Med Virol. 2022;94(1):44–53. doi: 10.1002/jmv.27281. PubMed PMID: 34411311; PubMed Central PMCID: PMCQ1. eng.
  • Burkholz S, Rubsamen M, Blankenberg L, et al. Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron. Commun Biol. 2023;6(1):288. doi: 10.1038/s42003-023-04687-4. PubMed PMID: 36934204; PubMed Central PMCID: PMCQ1. eng.
  • COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet. 2023;401(10379):833–842. doi: 10.1016/S0140-6736(22)02465-5. PubMed PMID: 36930674; PubMed Central PMCID: PMCQ1. eng.
  • Tan CY, Chiew CJ, Pang D, et al. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study. Lancet Infect Dis. 2023;23(7):799–805. doi: 10.1016/S1473-3099(23)00060-9. PubMed PMID: 36924786; PubMed Central PMCID: PMCQ1. eng.
  • Sacco C, Petrone D, Del Manso M, et al. Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022. Euro Surveill. 2022;27(20). doi: 10.2807/1560-7917.ES.2022.27.20.2200372. PubMed PMID: 35593164; PubMed Central PMCID: PMCQ1. eng.
  • Medic S, Anastassopoulou C, Lozanov-Crvenkovic Z, et al. Incidence, risk, and severity of SARS-CoV-2 reinfections in children and adolescents between March 2020 and July 2022 in Serbia. JAMA Netw Open. 2023;6(2):e2255779. doi: 10.1001/jamanetworkopen.2022.55779. PubMed PMID: 36780157; PubMed Central PMCID: PMCQ1. eng.